nach oben

European Archives of Psychiatry and Clinical Neuroscience

Erschienen in:

05.10.2015 | Short Communication

The intraindividual impact of ADHD on the transition of adulthood to old age

verfasst von: Florence Philipp-Wiegmann, Petra Retz-Junginger, Wolfgang Retz, Michael Rösler

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

The aim of the study was to explore whether the individual burden of ADHD is the same in the elderly as in younger ages even though the symptomatological impact of ADHD seems to remain stable over the lifespan. To assess ADHD symptoms and ADHD-associated problems in daily life, standardised questionnaires were conducted. To assess the subjectively experienced course of disease over the lifespan, all participants were interviewed regarding symptoms of ADHD in childhood as well as before and after the fiftieth year of life. In the sample of 296 respondents with a mean age of 69.55 years, 11 fulfilled the criteria of adult ADHD. Retrospectively, the ADHD subjects reported negative impacts due to ADHD-associated behaviour over the life span. These impairments remained stable over time with 18 % of subjects reporting impairments in family life, 46 % in social relationships, 18 % in dealing with money, and 36 % in organisation of daily life in the presence. Thus, the ADHD subjects reported problems with stability over time caused by low self-confidence, being quick-tempered, and due to defiantness. Although this is pilot study, our results reflect the burden of ADHD not only in young and middle adulthood, but also in seniority. The findings indicate the lifelong impact of ADHD as the explored seniors with ADHD reported the negative impact of ADHD remaining stable over the lifespan.

American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Washington. doi:10.1176/appi.books.9780890425596.744053

Biederman J, Faraone SV (2005) Attention-deficit hyperactivity disorder. Lancet 366(9481):237–248. doi:10.1016/s0140-6736(05)66915-2 CrossRefPubMed

Fayyad J, De Graaf R, Kessler RC, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C, Lépine JP, Ormel J, Posada-Villa J, Zaslavsky AM, Jin R (2007) Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 190(5):402–409. doi:10.1192/bjp.bp.106.034389 CrossRefPubMed

Bitter I, Simon V, Balint S, Meszaros A, Czobor P (2010) How do different diagnostic criteria, age and gender affect the prevalence of attention deficit hyperactivity disorder in adults? an epidemiological study in a Hungarian community sample. Eur Arch Psychiatry Clin Neurosci 260(4):287–296. doi:10.1007/s00406-009-0076-3 CrossRefPubMed

Brod M, Schmitt E, Goodwin M, Hodgins P, Niebler G (2011) ADHD burden of illness in older adults: a life course perspective. Qual Life Res 21:795–799. doi:10.1007/s11136-011-9981-9 CrossRefPubMed

Guldberg-Kjar T, Johansson B (2009) Old people reporting childhood AD/HD symptoms: retrospectively self-rated AD/HD symptoms in a population-based Swedish sample aged 65–80. Nord J Psychiatry 63(5):375–382. doi:10.1080/08039480902818238 CrossRefPubMed

Michielsen M, Semeijn E, Comijs HC, van de Ven P, Beekman AT, Deeg DJ, Kooij JJ (2012) Prevalence of attention-deficit hyperactivity disorder in older adults in The Netherlands. Br J Psychiatry 201(4):298–305. doi:10.1192/bjp.bp.111.101196 CrossRefPubMed

Semeijn EJ, Korten NC, Comijs HC, Michielsen M, Deeg DJ, Beekman AT, Kooij JJ (2015) No lower cognitive functioning in older adults with attention-deficit/hyperactivity disorder. Int Psychogeriatr 6:1–10. doi:10.1017/S1041610215000010

Huisman M, Poppelaars J, van der Horst M, Beekman AT, Brug J, van Tilburg TG, Deeg DJ (2011) Cohort profile: the longitudinal aging study Amsterdam. Int J Epidemiol 40(4):868–876. doi:10.1093/ije/dyq219 CrossRefPubMed

10.

Semeijn EJ, Comijs HC, Kooij JJ, Michielsen M, Beekman AT, Deeg DJ (2014) The role of adverse life events on depression in older adults with ADHD. J Affect Disord 174(15):574–579. doi:10.1016/j.jad.2014.11.048 PubMed

11.

Sobanski E, Brüggemann D, Alm B, Kern S, Deschner M, Schubert T, Philipsen A, Rietschel M (2007) Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 257(7):371–377. doi:10.1007/s00406-007-0712-8 CrossRefPubMed

12.

Barkley RA, Murphy K, Fischer M (2008) ADHD in Adults: What the Science Says. Guilford Publications, New York

13.

Brod M, Schmitt E, Goodwin M, Hodgkins P, Niebler G (2012) ADHD burden of illness in older adults: a life course perspective. Qual Life Res 21(5):795–799. doi:10.1007/s11136-011-9981-9 CrossRefPubMed

14.

Brod M, Johnston J, Able S, Swindle R (2006) Validation of the adult attention-deficit/hyperactivity disorder quality-of-life Scale (AAQoL): a disease-specific quality-of-life measure. Qual Life Res 15(1):117–129. doi:10.1007/s11136-005-8325-z CrossRefPubMed

15.

Brown B (2006) Shame resilience theory: a grounded theory study on women and shame. Fam Soc 87(1):43–52. doi:10.1606/1044-3894.3483 CrossRef

16.

Barkley RA, Murphy KR (2006) Attention-deficit hyperactivity disorder: a clinical workbook, 3rd edn. Guildford Press, New York

17.

Rösler M, Retz-Junginger P, Retz W, Stieglitz RD (2008) HASE—Homburger ADHS Skalen für Erwachsene. Hogrefe, Göttingen

18.

Rösler M, Retz W, Retz-Juninger P, Stieglitz RD, Reimherr F, Wender PH (2008) Attention deficit-/hyperactivity disorder(ADHD) in adults: benchmarking diagnosis using the Wender-Reimherr Adult ADHD Rating Scale (WRAADDS). Nervenarzt 79(3):320–327. doi:10.1007/s00115-007-2375-0 CrossRefPubMed

19.

Rösler M, Retz W, Thome J, Schneider M, Stieglitz RD, Falkai P (2006) Psychopathological rating scales for diagnostic use in adults with attention deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 256(1):3–11. doi:10.1007/s00406-006-1001-7 CrossRef

20.

Sheehan DV, Harnett-Sheehan K, Raj BA (1996) The measurement of disability. Int Clin Psychopharmacol 11(3):89–95. doi:10.1097/00004850-199606003-00015 CrossRefPubMed

21.

Ginsberg Y, Beusterien KM, Amos K, Jousselin C, Asherson P (2014) The unmet needs of all adults with ADHD are not the same: a focus on Europe. Expert Rev Neurother 14(7):799–812. doi:10.1586/14737175.2014.926220 CrossRefPubMed

22.

Seixas M, Weiss M, Müller U (2012) Systematic review of national and international guidelines on attention-deficit hyperactivity disorder. J Psychopharmacol 26(6):753–765. doi:10.1177/0269881111412095 CrossRefPubMed

23.

Manor I, Rozen S, Zemishlani Z, Weizman A, Zalsman G (2011) When does it end? attention-deficit/hyperactivity disorder in the middle aged and older populations. Clin Neuropharmacol 34(4):148–154. doi:10.1097/WNF.0b013e3182206dc1 CrossRefPubMed

24.

Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ (2003) Relative lack of cognitive effects of methylphenidate in elderly male volunteers. Psychopharmacology 168(4):455–464. doi:10.1007/s00213-003-1457-3 CrossRefPubMed

25.

Habel LA, Cooper WO, Sox CM, Chan KA, Fireman BH, Arbogast PG, Cheetham TC, Quinn VP, Dublin S, Boudreau DM, Andrade SE, Pawloski PA, Raebel MA, Smith DH, Achacoso N, Uratsu C, Go AS, Sidney S, Nguyen-Huynh MN, Ray WA, Selby JV (2011) ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA 306(24):2673–2683. doi:10.1001/jama.2011.1830 CrossRefPubMedPubMedCentral

26.

Lavretsky H, Reinlieb M, St Cyr N, Siddarth P, Ercoli LM, Senturk D (2015) Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry 172(6):561–569. doi:10.1176/appi.ajp.2014.14070889 CrossRefPubMedPubMedCentral

27.

Hunt RD, Arnsten AFT, Asbell MD (1995) An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34(1):50–54. doi:10.1097/00004583-199501000-00013 CrossRefPubMed

28.

Connor DF, Fletcher KE, Swanson JM (1999) A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 38(12):1551–1559. doi:10.1097/00004583-199912000-00017 CrossRefPubMed

29.

Spencer T, Biederman J, Wilens T (2004) Nonstimulant treatment of adult attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 27(2):373–383. doi:10.1016/j.psc.2003.12.001 CrossRefPubMed

30.

Wender PH (1998) Pharmacotherapy of attention-deficit/hyperactivity disorder in adults. J Clin Psychiatry 59(7):76–79PubMed

31.

Wilens TE, Biederman J, Spencer TJ (2002) Attention deficit/hyperactivity disorder across the lifespan. Annu Rev Med 53:113–131. doi:10.1146/annurev.med.53.082901.103945 CrossRefPubMed

32.

Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods AG, Arnold LE (2012) A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med 10:99. doi:10.1186/1741-7015-10-99 CrossRefPubMedPubMedCentral

33.

Brod M, Pohlman B, Lasser R, Hodgkins P (2012) Comparison of the burden of illness for adults with ADHD across seven countries: a qualitative study. Health Qual Life Outcomes. doi:10.1186/1477-7525-10-47 PubMedPubMedCentral

34.

Michielsen M, Comijs HC, Semeijn EJ, Beekman AT, Deeg DJ, Kooij JJ (2014) Attention deficit hyperactivity disorder and personality characteristics in older adults in the general Dutch population. Am Assoc Geriatr Psychiatry 22(12):1623–1632. doi:10.1016/j.jagp.2014.02.005 CrossRef

Titel: The intraindividual impact of ADHD on the transition of adulthood to old age
verfasst von: Florence Philipp-Wiegmann
Petra Retz-Junginger
Wolfgang Retz
Michael Rösler
Publikationsdatum: 05.10.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 4/2016
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-015-0644-7

Neu im Fachgebiet Psychiatrie

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The intraindividual impact of ADHD on the transition of adulthood to old age

Abstract

Neu im Fachgebiet Psychiatrie

Wartezeit nicht kürzer, aber Arbeit flexibler

Chirurginnen und Chirurgen sind stark suizidgefährdet

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

Update Psychiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2016

The age-dependent plasticity highlights the conceptual interface between borderline personality disorder and PTSD

Neurobiological background of borderline personality disorder, PTSD and ADHD

Altered lipid peroxidation markers are related to post-traumatic stress disorder (PTSD) and not trauma itself in earthquake survivors

Subjective experience of coercion in psychiatric care: a study comparing the attitudes of patients and healthy volunteers towards coercive methods and their justification

Altered intrinsic organisation of brain networks implicated in attentional processes in adult attention-deficit/hyperactivity disorder: a resting-state study of attention, default mode and salience network connectivity

Erratum to: FDG-PET scans in patients with Kraepelinian and non-Kraepelinian schizophrenia

Neu im Fachgebiet Psychiatrie

Wartezeit nicht kürzer, aber Arbeit flexibler

Chirurginnen und Chirurgen sind stark suizidgefährdet

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

Update Psychiatrie